David Baram: Founder and CEO of EmendoBio

Portrait of David Baram

David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

Atrium Banner
Alexion Pharmaceuticals

Atrium Corporate Intranet

Historical image of Shionogi employee in the lab.
Shionogi

140 Years

Overseas Shipholding Group

Moving Energy with Integrity